[시장보고서]바이오의약품 콜드체인 서드파티 물류 시장 규모, 점유율과 동향 분석 리포트 : 서비스별, 온도 범위별, 지역별, 부문 예측(2025-2033년)

바이오의약품 콜드체인 서드파티 물류 시장 규모, 점유율과 동향 분석 리포트 : 서비스별, 온도 범위별, 지역별, 부문 예측(2025-2033년)

Biopharmaceutical Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report By Services, By Temperature Range, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1869707

리서치사 : Grand View Research

발행일 : 2025년 10월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,845,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,332,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,305,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

바이오의약품 콜드체인 서드파티 물류 시장 요약

세계의 바이오의약품 콜드체인 서드파티 물류 시장 규모는 2024년에 305억 9,000만 달러로 추정되며, 2033년까지 744억 6,000만 달러에 달할 것으로 예측됩니다.

2025-2033년에는 CAGR 10.54%로 성장할 전망입니다. 이러한 시장 성장은 온도 관리가 필요한 의약품에 대한 수요 증가, 의약품 보관 및 운송에 대한 엄격한 규제 요건, 바이오의약품 및 백신 유통의 전 세계적 확대에 따른 것입니다.

또한 제약기업의 물류 서비스 아웃소싱이 증가하면서 시장 확대가 더욱 가속화되고 있습니다. 또한 생물제제, 백신, 온도 관리가 필요한 의약품에 대한 수요 증가로 인해 신뢰할 수 있는 콜드체인 물류 솔루션의 필요성이 크게 확대되고 있습니다. 단클론 항체, 유전자 치료제, 재조합 단백질 등의 생물제제는 그 효능을 유지하기 위해 보통 2°C에서 8°C 범위의 엄격한 온도 관리가 필요하며, 일부는 -70°C 이하의 초저온 보관을 필요로 하는 경우도 있습니다.

또한 맞춤형 의료에 대한 관심이 높아짐에 따라 공급망 전반에 걸쳐 제품의 무결성을 보장하기 위한 전문 물류 솔루션의 필요성이 더욱 커지고 있습니다.

시장 계통 전망
- 모시장 전망
- 관련/부수 시장 전망
시장 동향과 전망
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
기술적 상황
가격 모델 분석
업계 분석 툴
- Porter's Five Forces 분석
- PESTEL 분석
- COVID-19의 영향 분석

제4장 바이오의약품 콜드체인 서드파티 물류 시장 : 서비스 추정·동향 분석

부문 대시보드
바이오의약품 콜드체인 서드파티 물류 시장 : 서비스 변동 분석
바이오의약품 콜드체인 서드파티 물류 규모와 동향 분석(서비스별, 2021-2033년)
교통기관
- 항공화물
- 해상 화물
- 육로
창고·보관
포장 솔루션
감시 및 가시성 솔루션
재고 관리
기타

제5장 바이오의약품 콜드체인 서드파티 물류 시장 : 온도 범위 추정·동향 분석

부문 대시보드
바이오의약품 콜드체인 서드파티 물류 시장 : 온도 범위 변동 분석
바이오의약품 콜드체인 서드파티 물류 규모와 동향 분석(온도 범위별, 2021-2033년)
냉동
- 초냉동/급속냉동
- 극저온

제6장 지역 비즈니스 분석

지역 대시보드
시장 규모와 예측 및 동향 분석, 2021-2033년
북미
- 북미의 바이오의약품 콜드체인 서드파티 물류 시장, 2021-2033년
- 미국
- 캐나다
- 멕시코
유럽
- 유럽의 바이오의약품 콜드체인 서드파티 물류 시장, 2021-2033년
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 아시아태평양의 바이오의약품 콜드체인 서드파티 물류 시장, 2021-2033년
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 라틴아메리카의 바이오의약품 콜드체인 서드파티 물류 시장, 2021-2033년
- 브라질
- 아르헨티나
중동 및 아프리카
- 중동 및 아프리카의 바이오의약품 콜드체인 서드파티 물류 시장, 2021-2033년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
- 오만
- 카타르

제7장 경쟁 구도

기업 분류
기업 시장 현황 분석, 2024년
기업 개요
- Cardinal Health
- DHL Group
- Agility
- SF Express
- Kinesis Medical BV
- United Parcel Service of America, Inc.
- Barrett Distribution
- Cencora
- DB Schenker
- FedEx
- KUEHNE+NAGEL
- Kerry Logistics Network Ltd
- Freight Logistics Solutions

KSA

영문 목차

영문목차

Biopharmaceutical Cold Chain Third Party Logistics Market Summary

The global biopharmaceutical cold chain third party logistics market size was estimated at USD 30.59 billion in 2024 and is projected to reach USD 74.46 billion by 2033, growing at a CAGR of 10.54% from 2025 to 2033. This market growth is due to the rising demand for temperature-sensitive pharmaceuticals, stringent drug storage and transportation regulatory requirements, and the global expansion of biologics and vaccine distribution.

In addition, increasing outsourcing of logistics services by pharmaceutical companies is further driving market expansion. Furthermore, increasing demand for biologics, vaccines, and temperature-sensitive drugs has significantly expanded the need for reliable cold chain logistics solutions. Biologics, including monoclonal antibodies, gene therapies, and recombinant proteins, require stringent temperature control, typically between 2°C and 8°C, with some requiring ultra-low storage at -70°C or lower-to maintain their efficacy.

Moreover, the growing trend towards personalized medicine has further boosted the need for specialized logistics solutions to ensure product integrity throughout the supply chain.

Global Biopharmaceutical Cold Chain Third Party Logistics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global biopharmaceutical cold chain third party logistics market based on service, temperature range, and region:

Services Outlook (Revenue, USD Million, 2021 - 2033)
Transportation
- Air Freight
- Sea Freight
- Overland
Warehousing & Storage
Packaging Solutions
Monitoring & Visibility Solutions
Inventory Management
Others
Temperature Range Outlook (Revenue, USD Million, 2021 - 2033)
Frozen
Ultra-frozen/Deep-Frozen
Cryogenic
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Oman
- Qatar

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Analysis
- 1.3.1. Market Formulation & Data Visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
3.4. Technological Landscape
3.5. Pricing Model Analysis
3.6. Industry Analysis Tools
- 3.6.1. Porter's Five Forces Analysis
- 3.6.2. PESTEL Analysis
- 3.6.3. COVID-19 Impact Analysis

Chapter 4. Biopharmaceutical Cold Chain Third Party Logistics Market: Service Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Biopharmaceutical Cold Chain Third Party Logistics Market: Service Movement Analysis
4.3. Biopharmaceutical Cold Chain Third Party Logistics Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
4.4. Transportation
- 4.4.1. Transportation market estimates and forecasts 2021 - 2033 (USD Million)
- 4.4.2. Air Freight
  - 4.4.2.1. Air Freight market estimates and forecasts 2021 - 2033 (USD Million)
- 4.4.3. Sea Freight
  - 4.4.3.1. Sea Freight market estimates and forecasts 2021 - 2033 (USD Million)
- 4.4.4. Overland
  - 4.4.4.1. Overland market estimates and forecasts 2021 - 2033 (USD Million)
4.5. Warehousing & Storage
- 4.5.1. Warehousing & Storage market estimates and forecasts 2021 - 2033 (USD Million)
4.6. Packaging Solutions
- 4.6.1. Packaging Solutions market estimates and forecasts 2021 - 2033 (USD Million)
4.7. Monitoring & Visibility Solutions
- 4.7.1. Monitoring & Visibility Solutions market estimates and forecasts 2021 - 2033 (USD Million)
4.8. Inventory Management
- 4.8.1. Inventory Management market estimates and forecasts 2021 - 2033 (USD Million)
4.9. Others
- 4.9.1. Others market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 5. Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Movement Analysis
5.3. Biopharmaceutical Cold Chain Third Party Logistics Size & Trend Analysis, by Temperature Range, 2021 to 2033 (USD Million)
5.4. Frozen
- 5.4.1. Frozen market estimates and forecasts 2021 - 2033 (USD Million)
- 5.4.2. Ultra-frozen/Deep-Frozen
  - 5.4.2.1. Ultra-frozen/Deep-Frozen market estimates and forecasts 2021 - 2033 (USD Million)
- 5.4.3. Cryogenic
  - 5.4.3.1. Cryogenic market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 6. Regional Business Analysis

6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
6.3. North America
- 6.3.1. North America Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.3.2. U.S.
  - 6.3.2.1. Key Country Dynamics
  - 6.3.2.2. Competitive Scenario
  - 6.3.2.3. Regulatory Framework
  - 6.3.2.4. U.S. Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.3.3. Canada
  - 6.3.3.1. Key Country Dynamics
  - 6.3.3.2. Competitive Scenario
  - 6.3.3.3. Regulatory Framework
  - 6.3.3.4. Canada Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.3.4. Mexico
  - 6.3.4.1. Key Country Dynamics
  - 6.3.4.2. Competitive Scenario
  - 6.3.4.3. Regulatory Framework
  - 6.3.4.4. Mexico Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4. Europe
- 6.4.1. Europe Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.4.2. Germany
  - 6.4.2.1. Key Country Dynamics
  - 6.4.2.2. Competitive Scenario
  - 6.4.2.3. Regulatory Framework
  - 6.4.2.4. Germany Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.4.3. UK
  - 6.4.3.1. Key Country Dynamics
  - 6.4.3.2. Competitive Scenario
  - 6.4.3.3. Regulatory Framework
  - 6.4.3.4. UK Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.4.4. France
  - 6.4.4.1. Key Country Dynamics
  - 6.4.4.2. Competitive Scenario
  - 6.4.4.3. Regulatory Framework
  - 6.4.4.4. France Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.4.5. Italy
  - 6.4.5.1. Key Country Dynamics
  - 6.4.5.2. Competitive Scenario
  - 6.4.5.3. Regulatory Framework
  - 6.4.5.4. Italy Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.4.6. Spain
  - 6.4.6.1. Key Country Dynamics
  - 6.4.6.2. Competitive Scenario
  - 6.4.6.3. Regulatory Framework
  - 6.4.6.4. Spain Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.4.7. Denmark
  - 6.4.7.1. Key Country Dynamics
  - 6.4.7.2. Competitive Scenario
  - 6.4.7.3. Regulatory Framework
  - 6.4.7.4. Denmark Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.4.8. Sweden
  - 6.4.8.1. Key Country Dynamics
  - 6.4.8.2. Competitive Scenario
  - 6.4.8.3. Regulatory Framework
  - 6.4.8.4. Sweden Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.4.9. Norway
  - 6.4.9.1. Key Country Dynamics
  - 6.4.9.2. Competitive Scenario
  - 6.4.9.3. Regulatory Framework
  - 6.4.9.4. Norway Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.5. Asia Pacific
- 6.5.1. Asia Pacific Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.5.2. Japan
  - 6.5.2.1. Key Country Dynamics
  - 6.5.2.2. Competitive Scenario
  - 6.5.2.3. Regulatory Framework
  - 6.5.2.4. Japan Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.5.3. China
  - 6.5.3.1. Key Country Dynamics
  - 6.5.3.2. Competitive Scenario
  - 6.5.3.3. Regulatory Framework
  - 6.5.3.4. China Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.5.4. India
  - 6.5.4.1. Key Country Dynamics
  - 6.5.4.2. Competitive Scenario
  - 6.5.4.3. Regulatory Framework
  - 6.5.4.4. India Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.5.5. South Korea
  - 6.5.5.1. Key Country Dynamics
  - 6.5.5.2. Competitive Scenario
  - 6.5.5.3. Regulatory Framework
  - 6.5.5.4. South Korea Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.5.6. Australia
  - 6.5.6.1. Key Country Dynamics
  - 6.5.6.2. Competitive Scenario
  - 6.5.6.3. Regulatory Framework
  - 6.5.6.4. Australia Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.5.7. Thailand
  - 6.5.7.1. Key Country Dynamics
  - 6.5.7.2. Competitive Scenario
  - 6.5.7.3. Regulatory Framework
  - 6.5.7.4. Thailand Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.6. Latin America
- 6.6.1. Latin America Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.6.2. Brazil
  - 6.6.2.1. Key Country Dynamics
  - 6.6.2.2. Competitive Scenario
  - 6.6.2.3. Regulatory Framework
  - 6.6.2.4. Brazil Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.6.3. Argentina
  - 6.6.3.1. Key Country Dynamics
  - 6.6.3.2. Competitive Scenario
  - 6.6.3.3. Regulatory Framework
  - 6.6.3.4. Argentina Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.7. MEA
- 6.7.1. MEA Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.7.2. South Africa
  - 6.7.2.1. Key Country Dynamics
  - 6.7.2.2. Competitive Scenario
  - 6.7.2.3. Regulatory Framework
  - 6.7.2.4. South Africa Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.7.3. Saudi Arabia
  - 6.7.3.1. Key Country Dynamics
  - 6.7.3.2. Competitive Scenario
  - 6.7.3.3. Regulatory Framework
  - 6.7.3.4. Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.7.4. UAE
  - 6.7.4.1. Key Country Dynamics
  - 6.7.4.2. Competitive Scenario
  - 6.7.4.3. Regulatory Framework
  - 6.7.4.4. UAE Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.7.5. Kuwait
  - 6.7.5.1. Key Country Dynamics
  - 6.7.5.2. Competitive Scenario
  - 6.7.5.3. Regulatory Framework
  - 6.7.5.4. Kuwait Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.7.6. Oman
  - 6.7.6.1. Key Country Dynamics
  - 6.7.6.2. Competitive Scenario
  - 6.7.6.3. Regulatory Framework
  - 6.7.6.4. Oman Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
- 6.7.7. Qatar
  - 6.7.7.1. Key Country Dynamics
  - 6.7.7.2. Competitive Scenario
  - 6.7.7.3. Regulatory Framework
  - 6.7.7.4. Qatar Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

7.1. Company Categorization
7.2. Company Market Position Analysis, 2024
7.3. Company Profiles
- 7.3.1. Cardinal Health
  - 7.3.1.1. Company overview
  - 7.3.1.2. Financial performance
  - 7.3.1.3. Service benchmarking
  - 7.3.1.4. Strategic initiatives
- 7.3.2. DHL Group
  - 7.3.2.1. Company overview
  - 7.3.2.2. Financial performance
  - 7.3.2.3. Service benchmarking
  - 7.3.2.4. Strategic initiatives
- 7.3.3. Agility
  - 7.3.3.1. Company overview
  - 7.3.3.2. Financial performance
  - 7.3.3.3. Service benchmarking
  - 7.3.3.4. Strategic initiatives
- 7.3.4. SF Express
  - 7.3.4.1. Company overview
  - 7.3.4.2. Financial performance
  - 7.3.4.3. Service benchmarking
  - 7.3.4.4. Strategic initiatives
- 7.3.5. Kinesis Medical B.V.
  - 7.3.5.1. Company overview
  - 7.3.5.2. Financial performance
  - 7.3.5.3. Service benchmarking
  - 7.3.5.4. Strategic initiatives
- 7.3.6. United Parcel Service of America, Inc.
  - 7.3.6.1. Company overview
  - 7.3.6.2. Financial performance
  - 7.3.6.3. Service benchmarking
  - 7.3.6.4. Strategic initiatives
- 7.3.7. Barrett Distribution
  - 7.3.7.1. Company overview
  - 7.3.7.2. Financial performance
  - 7.3.7.3. Service benchmarking
  - 7.3.7.4. Strategic initiatives
- 7.3.8. Cencora
  - 7.3.8.1. Company overview
  - 7.3.8.2. Financial performance
  - 7.3.8.3. Service benchmarking
  - 7.3.8.4. Strategic initiatives
- 7.3.9. DB Schenker
  - 7.3.9.1. Company overview
  - 7.3.9.2. Financial performance
  - 7.3.9.3. Service benchmarking
  - 7.3.9.4. Strategic initiatives
- 7.3.10. FedEx
  - 7.3.10.1. Company overview
  - 7.3.10.2. Financial performance
  - 7.3.10.3. Service benchmarking
  - 7.3.10.4. Strategic initiatives
- 7.3.11. KUEHNE + NAGEL
  - 7.3.11.1. Company overview
  - 7.3.11.2. Financial performance
  - 7.3.11.3. Service benchmarking
  - 7.3.11.4. Strategic initiatives
- 7.3.12. Kerry Logistics Network Ltd
  - 7.3.12.1. Company overview
  - 7.3.12.2. Financial performance
  - 7.3.12.3. Service benchmarking
  - 7.3.12.4. Strategic initiatives
- 7.3.13. Freight Logistics Solutions
  - 7.3.13.1. Company overview
  - 7.3.13.2. Financial performance
  - 7.3.13.3. Service benchmarking
  - 7.3.13.4. Strategic initiatives